Star Imaging and Path Lab Ltd
Star Imaging and Path Lab Ltd (STARIMAGIN): company summary
The company's business is improving, with annual revenue rising 5.4% and annual net profit growing 20.5%.
Star Imaging and Path Lab Ltd (STARIMAGIN) is a micro-cap Healthcare Services company valued at ₹120 crore operating in Healthcare Service Provider on the NSE and BSE.
- Recent price move
- Star Imaging and Path Lab Ltd last traded at ₹69.1, sharply down 11.41% on the day.
- Financial performance
- The company's business is improving, with annual revenue rising 5.4% and annual net profit growing 20.5%. However, the latest quarter showed a decline in net profit, falling 10.0% compared to the same quarter a year earlier, despite a 4.9% increase in revenue.
- Valuation multiples
- The stock trades at 6.3 times earnings, 1.22 times book value.
- Things to watch
- The company's latest quarter net profit fell 10.0% compared to the same quarter a year earlier. The stock is 48.7% below its 52-week high, and the company's net profit margin, while up, is still lower than its peers in the healthcare sector.
- Where it stands
- Star Imaging and Path Lab Ltd has shown strong growth in both revenue and net profit over the past year, with a 168.1% profit CAGR over three years. However, the latest quarter's net profit decline highlights a potential challenge in maintaining profitability. The stock is currently 48.7% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by valuation (9.0) and growth (8.9), but held back by momentum (1.0). Valuation looks strong at 9.0, but that is offset by momentum at 1.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Profit compounding 168% a year
- Low leverage — D/E 0.18
- Profitable in all of the last 5 years
- Momentum is weak (1.0/10)
- Near the bottom of its 52-week range (22%)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare Services stocks · Healthcare Service Provider
Explore Star Imaging and Path Lab Ltd’s valuation
Free deep-dive tools · no sign-up
Star Imaging and Path Lab Ltd peers in Healthcare Services
Other Healthcare Services stocks on the NSE & BSE. See the full Healthcare Services sector list.
Related tools & concepts
Value Star Imaging and Path Lab Ltd with the ratios and calculators DocStoX uses in its analysis.

